{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:42:47Z","timestamp":1790833367057,"version":"4.1.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T00:00:00Z","timestamp":1704844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T00:00:00Z","timestamp":1704844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100011019","name":"NKFIH","doi-asserted-by":"crossref","award":["K142141"],"award-info":[{"award-number":["K142141"]}],"id":[{"id":"10.13039\/501100011019","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100011019","name":"NKFIH","doi-asserted-by":"crossref","award":["FK128387"],"award-info":[{"award-number":["FK128387"]}],"id":[{"id":"10.13039\/501100011019","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100011019","name":"NKFIH","doi-asserted-by":"crossref","award":["TKP2021-EGA-19"],"award-info":[{"award-number":["TKP2021-EGA-19"]}],"id":[{"id":"10.13039\/501100011019","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100011019","name":"NKFIH","doi-asserted-by":"crossref","award":["TKP2021-EGA-20"],"award-info":[{"award-number":["TKP2021-EGA-20"]}],"id":[{"id":"10.13039\/501100011019","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003825","name":"Magyar Tudom\u00e1nyos Akad\u00e9mia","doi-asserted-by":"publisher","award":["Bolyai Fellowship"],"award-info":[{"award-number":["Bolyai Fellowship"]}],"id":[{"id":"10.13039\/501100003825","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003825","name":"Magyar Tudom\u00e1nyos Akad\u00e9mia","doi-asserted-by":"publisher","award":["NKM2022-30"],"award-info":[{"award-number":["NKM2022-30"]}],"id":[{"id":"10.13039\/501100003825","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003825","name":"Magyar Tudom\u00e1nyos Akad\u00e9mia","doi-asserted-by":"publisher","award":["POST-COVID2021-33"],"award-info":[{"award-number":["POST-COVID2021-33"]}],"id":[{"id":"10.13039\/501100003825","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011019","name":"Nemzeti Kutat\u00e1si Fejleszt\u00e9si \u00e9s Innov\u00e1ci\u00f3s Hivatal","doi-asserted-by":"publisher","award":["FK146852"],"award-info":[{"award-number":["FK146852"]}],"id":[{"id":"10.13039\/501100011019","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009232","name":"University of Debrecen","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009232","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["GeroScience"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Ascites plays a key role in supporting the metastatic potential of ovarian cancer cells. Shear stress and carry-over of cancer cells by ascites flow support carcinogenesis and metastasis formation. In addition, soluble factors may participate in the procarcinogenic effects of ascites in ovarian cancer. This study aimed to determine the biological effects of cell-free ascites on carcinogenesis in ovarian cancer cells. Cell-free ascites from ovarian cancer patients (ASC) non-selectively induced cell proliferation in multiple models of ovarian cancer and untransformed primary human dermal fibroblasts. Furthermore, ASC induced a Warburg-type rearrangement of cellular metabolism in A2780 ovarian cancer cells characterized by increases in cellular oxygen consumption and glycolytic flux; increases in glycolytic flux were dominant. ASC induced mitochondrial uncoupling and fundamentally reduced fatty acid oxidation. Ascites-elicited effects were uniform among ascites specimens. ASC-elicited transcriptomic changes in A2780 ovarian cancer cells included induction of the TGF\u03b2-ERK\/MEK pathway, which plays a key role in inducing cell proliferation and oncometabolism. ASC-induced gene expression changes, as well as the overexpression of members of the TGF\u03b2 signaling system, were associated with poor survival in ovarian cancer patients. We provided evidence that the activation of the autocrine\/paracrine of TGF\u03b2 signaling system may be present in bladder urothelial carcinoma and stomach adenocarcinoma. Database analysis suggests that the TGF\u03b2 system may feed forward bladder urothelial carcinoma and stomach adenocarcinoma. Soluble components of ASC support the progression of ovarian cancer. These results suggest that reducing ascites production may play an essential role in the treatment of ovarian cancer by inhibiting the progression and reducing the severity of the disease.<\/jats:p>","DOI":"10.1007\/s11357-023-01056-1","type":"journal-article","created":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T21:01:46Z","timestamp":1704834106000},"page":"3581-3597","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Cell-free ascites from ovarian cancer patients induces Warburg metabolism and cell proliferation through TGF\u03b2-ERK signaling"],"prefix":"10.1007","volume":"46","author":[{"given":"D\u00f3ra","family":"Sze\u0151cs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Be\u00e1ta","family":"Vida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e1bor","family":"Pet\u0151v\u00e1ri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Szil\u00e1rd","family":"P\u00f3liska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eszter","family":"Janka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrienn","family":"Sipos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Uray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Sebesty\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zo\u00e1rd","family":"Krasznai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6191-6616","authenticated-orcid":false,"given":"P\u00e9ter","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,10]]},"reference":[{"issue":"4","key":"1056_CR1","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3322\/caac.21456","volume":"68","author":"LA Torre","year":"2018","unstructured":"Torre LA, Trabert B, DeSantis CE, Miller KD, Samimi G, Runowicz CD, et al. Ovarian cancer statistics, 2018. CA Cancer J Clin. 2018;68(4):284\u201396.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"1056_CR2","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1093\/annonc\/mdz062","volume":"30","author":"N Colombo","year":"2019","unstructured":"Colombo N, Sessa C, du Bois A, Ledermann J, McCluggage WG, McNeish I, et al. ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease. Ann Oncol. 2019;30(5):672\u2013705.","journal-title":"Ann Oncol"},{"key":"1056_CR3","unstructured":"UK CR. Ovarian cancer statistics [Available from: https:\/\/www.cancerresearchuk.org\/health-professional\/cancer-statistics\/statistics-by-cancer-type\/ovarian-cancer#heading-Zero. Accessed 26 Jul 2023."},{"key":"1056_CR4","unstructured":"NCI N. Cancer stat facts: ovarian cancer [Available from: https:\/\/seer.cancer.gov\/statfacts\/html\/ovary.html. Accessed 26 Jul 2023."},{"issue":"1","key":"1056_CR5","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13048-017-0331-6","volume":"10","author":"F Deng","year":"2017","unstructured":"Deng F, Xu X, Lv M, Ren B, Wang Y, Guo W, et al. Age is associated with prognosis in serous ovarian carcinoma. Journal of Ovarian Research. 2017;10(1):36.","journal-title":"Journal of Ovarian Research"},{"key":"1056_CR6","doi-asserted-by":"crossref","unstructured":"Ries LA. Ovarian cancer. Survival and treatment differences by age. Cancer. 1993;71(2 Suppl):524\u20139.","DOI":"10.1002\/cncr.2820710206"},{"issue":"10","key":"1056_CR7","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1038\/sj.bjc.6603457","volume":"95","author":"JK Chan","year":"2006","unstructured":"Chan JK, Urban R, Cheung MK, Osann K, Shin JY, Husain A, et al. Ovarian cancer in younger vs older women: a population-based analysis. Br J Cancer. 2006;95(10):1314\u201320.","journal-title":"Br J Cancer"},{"key":"1056_CR8","doi-asserted-by":"crossref","unstructured":"Rickard BP, Conrad C, Sorrin AJ, Ruhi MK, Reader JC, Huang SA, et al. Malignant ascites in ovarian cancer: cellular, acellular, and biophysical determinants of molecular characteristics and therapy response. Cancers (Basel). 2021;13(17).","DOI":"10.3390\/cancers13174318"},{"issue":"1","key":"1056_CR9","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1757-2215-5-34","volume":"5","author":"D Lane","year":"2012","unstructured":"Lane D, Matte I, Rancourt C, Pich\u00e9 A. Osteoprotegerin (OPG) protects ovarian cancer cells from TRAIL-induced apoptosis but does not contribute to malignant ascites-mediated attenuation of TRAIL-induced apoptosis. J Ovarian Res. 2012;5(1):34.","journal-title":"J Ovarian Res"},{"key":"1056_CR10","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/1476-4598-11-84","volume":"11","author":"N Goncharenko-Khaider","year":"2012","unstructured":"Goncharenko-Khaider N, Matte I, Lane D, Rancourt C, Pich\u00e9 A. Ovarian cancer ascites increase Mcl-1 expression in tumor cells through ERK1\/2-Elk-1 signaling to attenuate TRAIL-induced apoptosis. Mol Cancer. 2012;11:84.","journal-title":"Mol Cancer"},{"issue":"1","key":"1056_CR11","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s12943-018-0787-z","volume":"17","author":"J Pasquier","year":"2018","unstructured":"Pasquier J, Gosset M, Geyl C, Hoarau-V\u00e9chot J, Chevrot A, Pocard M, et al. CCL2\/CCL5 secreted by the stroma induce IL-6\/PYK2 dependent chemoresistance in ovarian cancer. Mol Cancer. 2018;17(1):47.","journal-title":"Mol Cancer"},{"issue":"18","key":"1056_CR12","doi-asserted-by":"publisher","first-page":"4702","DOI":"10.3390\/cancers13184702","volume":"13","author":"M Wr\u00f3blewski","year":"2021","unstructured":"Wr\u00f3blewski M, Szewczyk-Golec K, Ho\u0142y\u0144ska-Iwan I, Wr\u00f3blewska J, Wo\u017aniak A. characteristics of selected adipokines in ascites and blood of ovarian cancer patients. Cancers (Basel). 2021;13(18):4702.","journal-title":"Cancers (Basel)."},{"key":"1056_CR13","doi-asserted-by":"crossref","unstructured":"Dalal V, Kumar R, Kumar S, Sharma A, Kumar L, Sharma JB, et al. Biomarker potential of IL-6 and VEGF-A in ascitic fluid of epithelial ovarian cancer patients. Clinica chimica acta; international journal of clinical chemistry. 2018;482:27\u201332.","DOI":"10.1016\/j.cca.2018.03.019"},{"issue":"3","key":"1056_CR14","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1177\/172460080702200302","volume":"22","author":"M Chechlinska","year":"2007","unstructured":"Chechlinska M, Kaminska J, Markowska J, Kramar A, Steffen J. Peritoneal fluid cytokines and the differential diagnosis of benign and malignant ovarian tumors and residual\/recurrent disease examination. Int J Biol Markers. 2007;22(3):172\u201380.","journal-title":"Int J Biol Markers"},{"key":"1056_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215735","volume":"542","author":"W Wang","year":"2022","unstructured":"Wang W, Jo H, Park S, Kim H, Kim SI, Han Y, et al. Integrated analysis of ascites and plasma extracellular vesicles identifies a miRNA-based diagnostic signature in ovarian cancer. Cancer Lett. 2022;542: 215735.","journal-title":"Cancer Lett"},{"key":"1056_CR16","doi-asserted-by":"crossref","unstructured":"Pascual-Ant\u00f3n L, Carde\u00f1es B, Sainz de la Cuesta R, Gonz\u00e1lez-Cortijo L, L\u00f3pez-Cabrera M, Caba\u00f1as C, et al. Mesothelial-to-mesenchymal transition and exosomes in peritoneal metastasis of ovarian cancer. Int J Mol Sci. 2021;22(21):11496.","DOI":"10.3390\/ijms222111496"},{"issue":"3","key":"1056_CR17","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.ygyno.2007.08.064","volume":"107","author":"S Runz","year":"2007","unstructured":"Runz S, Keller S, Rupp C, Stoeck A, Issa Y, Koensgen D, et al. Malignant ascites-derived exosomes of ovarian carcinoma patients contain CD24 and EpCAM. Gynecol Oncol. 2007;107(3):563\u201371.","journal-title":"Gynecol Oncol"},{"issue":"19","key":"1056_CR18","doi-asserted-by":"publisher","first-page":"7045","DOI":"10.1158\/0008-5472.CAN-04-1800","volume":"64","author":"LE Graves","year":"2004","unstructured":"Graves LE, Ariztia EV, Navari JR, Matzel HJ, Stack MS, Fishman DA. Proinvasive properties of ovarian cancer ascites-derived membrane vesicles. Cancer Res. 2004;64(19):7045\u20139.","journal-title":"Cancer Res"},{"issue":"4","key":"1056_CR19","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41419-020-2438-8","volume":"11","author":"AM Steitz","year":"2020","unstructured":"Steitz AM, Steffes A, Finkernagel F, Unger A, Sommerfeld L, Jansen JM, et al. Tumor-associated macrophages promote ovarian cancer cell migration by secreting transforming growth factor beta induced (TGFBI) and tenascin C. Cell Death Dis. 2020;11(4):249.","journal-title":"Cell Death Dis"},{"issue":"9","key":"1056_CR20","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1038\/sj.bjc.6602536","volume":"92","author":"H Yagi","year":"2005","unstructured":"Yagi H, Miyamoto S, Tanaka Y, Sonoda K, Kobayashi H, Kishikawa T, et al. Clinical significance of heparin-binding epidermal growth factor-like growth factor in peritoneal fluid of ovarian cancer. Br J Cancer. 2005;92(9):1737\u201345.","journal-title":"Br J Cancer"},{"issue":"9","key":"1056_CR21","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/nrc2714","volume":"9","author":"MB Meads","year":"2009","unstructured":"Meads MB, Gatenby RA, Dalton WS. Environment-mediated drug resistance: a major contributor to minimal residual disease. Nat Rev Cancer. 2009;9(9):665\u201374.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"1056_CR22","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1186\/s12885-018-5152-5","volume":"18","author":"S Kim","year":"2018","unstructured":"Kim S, Lee M, Dhanasekaran DN, Song YS. Activation of LXR\u0251\/\u03b2 by cholesterol in malignant ascites promotes chemoresistance in ovarian cancer. BMC Cancer. 2018;18(1):1232.","journal-title":"BMC Cancer"},{"issue":"1","key":"1056_CR23","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s10020-021-00295-2","volume":"27","author":"A Sipos","year":"2021","unstructured":"Sipos A, Ujlaki G, Mik\u00f3 E, Maka E, Szab\u00f3 J, Uray K, et al. The role of the microbiome in ovarian cancer: mechanistic insights into oncobiosis and to bacterial metabolite signaling. Molecular medicine (Cambridge, Mass). 2021;27(1):33.","journal-title":"Molecular medicine (Cambridge, Mass)"},{"issue":"8","key":"1056_CR24","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.1158\/1078-0432.CCR-16-1647","volume":"23","author":"A Bachmayr-Heyda","year":"2017","unstructured":"Bachmayr-Heyda A, Aust S, Auer K, Meier SM, Schmetterer KG, Dekan S, et al. Integrative systemic and local metabolomics with impact on survival in high-grade serous ovarian cancer. Clin Cancer Res. 2017;23(8):2081\u201392.","journal-title":"Clin Cancer Res"},{"key":"1056_CR25","doi-asserted-by":"publisher","first-page":"4101","DOI":"10.1016\/j.csbj.2021.07.014","volume":"19","author":"B Gy\u0151rffy","year":"2021","unstructured":"Gy\u0151rffy B. Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancer. Comput Struct Biotechnol J. 2021;19:4101\u20139.","journal-title":"Comput Struct Biotechnol J"},{"issue":"6","key":"1056_CR26","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1085\/jgp.8.6.519","volume":"8","author":"O Warburg","year":"1927","unstructured":"Warburg O, Wind F, Negelein E. The metabolism of tumors in the body. J Gen Physiol. 1927;8(6):519\u201330.","journal-title":"J Gen Physiol"},{"issue":"5","key":"1056_CR27","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646\u201374.","journal-title":"Cell"},{"key":"1056_CR28","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/514310","volume":"2010","author":"LD Kellenberger","year":"2010","unstructured":"Kellenberger LD, Bruin JE, Greenaway J, Campbell NE, Moorehead RA, Holloway AC, et al. The role of dysregulated glucose metabolism in epithelial ovarian cancer. Journal of oncology. 2010;2010: 514310.","journal-title":"Journal of oncology"},{"issue":"31","key":"1056_CR29","doi-asserted-by":"publisher","first-page":"30704","DOI":"10.18632\/oncotarget.5228","volume":"6","author":"M Mandai","year":"2015","unstructured":"Mandai M, Amano Y, Yamaguchi K, Matsumura N, Baba T, Konishi I. Ovarian clear cell carcinoma meets metabolism; HNF-1\u03b2 confers survival benefits through the Warburg effect and ROS reduction. Oncotarget. 2015;6(31):30704\u201314.","journal-title":"Oncotarget"},{"issue":"9","key":"1056_CR30","first-page":"9950","volume":"13","author":"C Nantasupha","year":"2021","unstructured":"Nantasupha C, Thonusin C, Charoenkwan K, Chattipakorn S, Chattipakorn N. Metabolic reprogramming in epithelial ovarian cancer. Am J Transl Res. 2021;13(9):9950\u201373.","journal-title":"Am J Transl Res"},{"key":"1056_CR31","doi-asserted-by":"crossref","unstructured":"Tondo-Steele K, McLean K. The \u201csweet spot\u201d of targeting tumor metabolism in ovarian cancers. Cancers (Basel). 2022;14(19):4696.","DOI":"10.3390\/cancers14194696"},{"issue":"2","key":"1056_CR32","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1073\/pnas.0912742107","volume":"107","author":"A Rasola","year":"2010","unstructured":"Rasola A, Sciacovelli M, Chiara F, Pantic B, Brusilow WS, Bernardi P. Activation of mitochondrial ERK protects cancer cells from death through inhibition of the permeability transition. Proc Natl Acad Sci U S A. 2010;107(2):726\u201331.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"24","key":"1056_CR33","doi-asserted-by":"publisher","first-page":"4177","DOI":"10.1111\/febs.14122","volume":"284","author":"SJ Cook","year":"2017","unstructured":"Cook SJ, Stuart K, Gilley R, Sale MJ. Control of cell death and mitochondrial fission by ERK1\/2 MAP kinase signalling. Febs j. 2017;284(24):4177\u201395.","journal-title":"Febs j"},{"issue":"1","key":"1056_CR34","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.ydbio.2017.11.009","volume":"434","author":"D Tomer","year":"2018","unstructured":"Tomer D, Chippalkatti R, Mitra K, Rikhy R. ERK regulates mitochondrial membrane potential in fission deficient Drosophila follicle cells during differentiation. Dev Biol. 2018;434(1):48\u201362.","journal-title":"Dev Biol"},{"issue":"1","key":"1056_CR35","doi-asserted-by":"publisher","first-page":"11124","DOI":"10.1038\/ncomms11124","volume":"7","author":"J Prieto","year":"2016","unstructured":"Prieto J, Le\u00f3n M, Ponsoda X, Sendra R, Bort R, Ferrer-Lorente R, et al. Early ERK1\/2 activation promotes DRP1-dependent mitochondrial fission necessary for cell reprogramming. Nat Commun. 2016;7(1):11124.","journal-title":"Nat Commun"},{"issue":"6","key":"1056_CR36","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13048","volume":"54","author":"W Feng","year":"2021","unstructured":"Feng W, Wang J, Yan X, Zhang Q, Chai L, Wang Q, et al. ERK\/Drp1-dependent mitochondrial fission contributes to HMGB1-induced autophagy in pulmonary arterial hypertension. Cell Prolif. 2021;54(6): e13048.","journal-title":"Cell Prolif"},{"issue":"9","key":"1056_CR37","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1002\/2211-5463.13452","volume":"12","author":"S Bandopadhyay","year":"2022","unstructured":"Bandopadhyay S, Prasad P, Ray U, Das Ghosh D, Roy SS. SIRT6 promotes mitochondrial fission and subsequent cellular invasion in ovarian cancer. FEBS Open Bio. 2022;12(9):1657\u201376.","journal-title":"FEBS Open Bio"},{"key":"1056_CR38","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.971479","volume":"12","author":"Y Wu","year":"2022","unstructured":"Wu Y, Zhang X, Wang Z, Zheng W, Cao H, Shen W. Targeting oxidative phosphorylation as an approach for the treatment of ovarian cancer. Front Oncol. 2022;12: 971479.","journal-title":"Front Oncol"},{"issue":"2","key":"1056_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2021.112549","volume":"401","author":"L Shen","year":"2021","unstructured":"Shen L, Xia M, Zhang Y, Luo H, Dong D, Sun L. Mitochondrial integration and ovarian cancer chemotherapy resistance. Exp Cell Res. 2021;401(2): 112549.","journal-title":"Exp Cell Res"},{"issue":"13","key":"1056_CR40","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1089\/ars.2019.7902","volume":"33","author":"P Je\u017eek","year":"2020","unstructured":"Je\u017eek P. 2-hydroxyglutarate in cancer cells. Antioxid Redox Signal. 2020;33(13):903\u201326.","journal-title":"Antioxid Redox Signal"},{"issue":"33","key":"1056_CR41","doi-asserted-by":"publisher","first-page":"11938","DOI":"10.1074\/jbc.REV119.007624","volume":"295","author":"YP Wang","year":"2020","unstructured":"Wang YP, Li JT, Qu J, Yin M, Lei QY. Metabolite sensing and signaling in cancer. J Biol Chem. 2020;295(33):11938\u201346.","journal-title":"J Biol Chem"},{"key":"1056_CR42","doi-asserted-by":"crossref","unstructured":"Uruski P, Miku\u0142a-Pietrasik J, Paku\u0142a M, Budkiewicz S, Drzewiecki M, Gaiday AN, et al. Malignant ascites promote adhesion of ovarian cancer cells to peritoneal mesothelium and fibroblasts. Int J Mol Sci. 2021;22(8):4222.","DOI":"10.3390\/ijms22084222"},{"issue":"11","key":"1056_CR43","doi-asserted-by":"publisher","first-page":"2668","DOI":"10.1038\/s41596-022-00729-z","volume":"17","author":"MK Kilgour","year":"2022","unstructured":"Kilgour MK, MacPherson S, Zacharias LG, LeBlanc J, Babinszky S, Kowalchuk G, et al. Principles of reproducible metabolite profiling of enriched lymphocytes in tumors and ascites from human ovarian cancer. Nat Protoc. 2022;17(11):2668\u201398.","journal-title":"Nat Protoc."},{"issue":"1","key":"1056_CR44","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/nm0195-74","volume":"1","author":"DJ Grainger","year":"1995","unstructured":"Grainger DJ, Kemp PR, Metcalfe JC, Liu AC, Lawn RM, Williams NR, et al. The serum concentration of active transforming growth factor-\u03b2 is severely depressed in advanced atherosclerosis. Nat Med. 1995;1(1):74\u20139.","journal-title":"Nat Med"},{"issue":"2","key":"1056_CR45","first-page":"189","volume":"57","author":"B Czarkowska-Paczek","year":"2006","unstructured":"Czarkowska-Paczek B, Bartlomiejczyk I, Przybylski J. The serum levels of growth factors: PDGF, TGF-beta and VEGF are increased after strenuous physical exercise. J Physiol Pharmacol. 2006;57(2):189\u201397.","journal-title":"J Physiol Pharmacol"},{"issue":"8","key":"1056_CR46","first-page":"804","volume":"108","author":"AD Santin","year":"2001","unstructured":"Santin AD, Bellone S, Ravaggi A, Roman J, Smith CV, Pecorelli S, et al. Increased levels of interleukin-10 and transforming growth factor-beta in the plasma and ascitic fluid of patients with advanced ovarian cancer. BJOG\u202f: an international journal of obstetrics and gynaecology. 2001;108(8):804\u20138.","journal-title":"BJOG : an international journal of obstetrics and gynaecology"},{"issue":"6","key":"1056_CR47","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1111\/j.1474-9728.2004.00129.x","volume":"3","author":"G Carrieri","year":"2004","unstructured":"Carrieri G, Marzi E, Olivieri F, Marchegiani F, Cavallone L, Cardelli M, et al. The G\/C915 polymorphism of transforming growth factor beta1 is associated with human longevity: a study in Italian centenarians. Aging Cell. 2004;3(6):443\u20138.","journal-title":"Aging Cell"},{"issue":"11","key":"1056_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1003941","volume":"9","author":"H Bai","year":"2013","unstructured":"Bai H, Kang P, Hernandez AM, Tatar M. Activin signaling targeted by insulin\/dFOXO regulates aging and muscle proteostasis in Drosophila. PLoS Genet. 2013;9(11): e1003941.","journal-title":"PLoS Genet"},{"issue":"3","key":"1056_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2023.112129","volume":"42","author":"S Matsuda","year":"2023","unstructured":"Matsuda S, Revandkar A, Dubash TD, Ravi A, Wittner BS, Lin M, et al. TGF-\u03b2 in the microenvironment induces a physiologically occurring immune-suppressive senescent state. Cell Rep. 2023;42(3): 112129.","journal-title":"Cell Rep"},{"key":"1056_CR50","doi-asserted-by":"crossref","unstructured":"Zhang Y, Alexander PB, Wang XF. TGF-\u03b2 family signaling in the control of cell proliferation and survival. Cold Spring Harb Perspect Biol. 2017;9(4):a022145.","DOI":"10.1101\/cshperspect.a022145"},{"key":"1056_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.998475","volume":"9","author":"SC Samson","year":"2022","unstructured":"Samson SC, Khan AM, Mendoza MC. ERK signaling for cell migration and invasion. Front Mol Biosci. 2022;9: 998475.","journal-title":"Front Mol Biosci"},{"issue":"5600","key":"1056_CR52","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1126\/science.1072682","volume":"298","author":"GL Johnson","year":"2002","unstructured":"Johnson GL, Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science. 2002;298(5600):1911\u20132.","journal-title":"Science"},{"issue":"1\u20132","key":"1056_CR53","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S1359-6101(99)00026-X","volume":"11","author":"KM Mulder","year":"2000","unstructured":"Mulder KM. Role of Ras and Mapks in TGFbeta signaling. Cytokine Growth Factor Rev. 2000;11(1\u20132):23\u201335.","journal-title":"Cytokine Growth Factor Rev"},{"issue":"1","key":"1056_CR54","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ygyno.2012.12.031","volume":"129","author":"MH Pourgholami","year":"2013","unstructured":"Pourgholami MH, Ataie-Kachoie P, Badar S, Morris DL. Minocycline inhibits malignant ascites of ovarian cancer through targeting multiple signaling pathways. Gynecol Oncol. 2013;129(1):113\u20139.","journal-title":"Gynecol Oncol"},{"issue":"22","key":"1056_CR55","doi-asserted-by":"publisher","first-page":"3446","DOI":"10.1002\/cncr.28864","volume":"120","author":"M Burotto","year":"2014","unstructured":"Burotto M, Chiou VL, Lee JM, Kohn EC. The MAPK pathway across different malignancies: a new perspective. Cancer. 2014;120(22):3446\u201356.","journal-title":"Cancer"},{"issue":"4","key":"1056_CR56","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.bbrc.2020.02.028","volume":"524","author":"S Jin","year":"2020","unstructured":"Jin S, Gao J, Qi Y, Hao Y, Li X, Liu Q, et al. TGF-\u03b21 fucosylation enhances the autophagy and mitophagy via PI3K\/Akt and Ras-Raf-MEK-ERK in ovarian carcinoma. Biochem Biophys Res Commun. 2020;524(4):970\u20136.","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"1056_CR57","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s00018-022-04595-6","volume":"79","author":"R Ashraf","year":"2022","unstructured":"Ashraf R, Kumar S. Mfn2-mediated mitochondrial fusion promotes autophagy and suppresses ovarian cancer progression by reducing ROS through AMPK\/mTOR\/ERK signaling. Cell Mol Life Sci. 2022;79(11):573.","journal-title":"Cell Mol Life Sci"},{"issue":"9","key":"1056_CR58","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1038\/s42255-022-00636-3","volume":"4","author":"A Achreja","year":"2022","unstructured":"Achreja A, Yu T, Mittal A, Choppara S, Animasahun O, Nenwani M, et al. Metabolic collateral lethal target identification reveals MTHFD2 paralogue dependency in ovarian cancer. Nat Metab. 2022;4(9):1119\u201337.","journal-title":"Nat Metab"},{"issue":"8","key":"1056_CR59","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbabio.2022.148915","volume":"1863","author":"JT Hagen","year":"2022","unstructured":"Hagen JT, Montgomery MM, Biagioni EM, Krassovskaia P, Jevtovic F, Shookster D, et al. Intrinsic adaptations in OXPHOS power output and reduced tumorigenicity characterize doxorubicin resistant ovarian cancer cells. Biochim Biophys Acta. 2022;1863(8): 148915.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"1056_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2021.188563","volume":"1876","author":"K Tyagi","year":"2021","unstructured":"Tyagi K, Mandal S, Roy A. Recent advancements in therapeutic targeting of the Warburg effect in refractory ovarian cancer: a promise towards disease remission. Biochim Biophys Acta Rev Cancer. 2021;1876(1): 188563.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"12","key":"1056_CR61","doi-asserted-by":"publisher","first-page":"3578","DOI":"10.1002\/1878-0261.13028","volume":"15","author":"Y Ding","year":"2021","unstructured":"Ding Y, Labitzky V, Legler K, Qi M, Schumacher U, Schmalfeldt B, et al. Molecular characteristics and tumorigenicity of ascites-derived tumor cells: mitochondrial oxidative phosphorylation as a novel therapy target in ovarian cancer. Mol Oncol. 2021;15(12):3578\u201395.","journal-title":"Mol Oncol"},{"issue":"Suppl 6","key":"1056_CR62","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.1038\/sj.ijo.0800937","volume":"23","author":"RK Porter","year":"1999","unstructured":"Porter RK, Joyce OJ, Farmer MK, Heneghan R, Tipton KF, Andrews JF, et al. Indirect measurement of mitochondrial proton leak and its application. Int J Obes Relat Metab Disord. 1999;23(Suppl 6):S12\u20138.","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"11","key":"1056_CR63","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2016.230","volume":"6","author":"E Kristof","year":"2016","unstructured":"Kristof E, Doan-Xuan QM, Sarvari AK, Klusoczki A, Fischer-Posovszky P, Wabitsch M, et al. Clozapine modifies the differentiation program of human adipocytes inducing browning. Transl Psychiatry. 2016;6(11): e963.","journal-title":"Transl Psychiatry"},{"key":"1056_CR64","doi-asserted-by":"crossref","unstructured":"Baffy G. Mitochondrial uncoupling in cancer cells: liabilities and opportunities. Biochimica et Biophysica Acta (BBA) - Bioenergetics. 2017;1858(8):655\u201364.","DOI":"10.1016\/j.bbabio.2017.01.005"},{"key":"1056_CR65","doi-asserted-by":"publisher","first-page":"768","DOI":"10.18632\/oncotarget.28241","volume":"13","author":"S Chaudhry","year":"2022","unstructured":"Chaudhry S, Thomas SN, Simmons GE Jr. Targeting lipid metabolism in the treatment of ovarian cancer. Oncotarget. 2022;13:768\u201383.","journal-title":"Oncotarget"},{"issue":"1","key":"1056_CR66","doi-asserted-by":"publisher","first-page":"4554","DOI":"10.1038\/s41467-022-32101-w","volume":"13","author":"Y Tan","year":"2022","unstructured":"Tan Y, Li J, Zhao G, Huang KC, Cardenas H, Wang Y, et al. Metabolic reprogramming from glycolysis to fatty acid uptake and beta-oxidation in platinum-resistant cancer cells. Nat Commun. 2022;13(1):4554.","journal-title":"Nat Commun"},{"issue":"7","key":"1056_CR67","doi-asserted-by":"publisher","first-page":"3534","DOI":"10.7150\/thno.70194","volume":"12","author":"Y Xuan","year":"2022","unstructured":"Xuan Y, Wang H, Yung MM, Chen F, Chan WS, Chan YS, et al. SCD1\/FADS2 fatty acid desaturases equipoise lipid metabolic activity and redox-driven ferroptosis in ascites-derived ovarian cancer cells. Theranostics. 2022;12(7):3534\u201352.","journal-title":"Theranostics"},{"issue":"6","key":"1056_CR68","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41419-022-05014-1","volume":"13","author":"Y Huang","year":"2022","unstructured":"Huang Y, Du Y, Zheng Y, Wen C, Zou H, Huang J, et al. Ct-OATP1B3 promotes high-grade serous ovarian cancer metastasis by regulation of fatty acid beta-oxidation and oxidative phosphorylation. Cell Death Dis. 2022;13(6):556.","journal-title":"Cell Death Dis"},{"key":"1056_CR69","doi-asserted-by":"crossref","unstructured":"Heiserman JP, Nallanthighal S, Gifford CC, Graham K, Samarakoon R, Gao C, et al. Heat shock protein 27, a novel downstream target of collagen type xi alpha 1, synergizes with fatty acid oxidation to confer cisplatin resistance in ovarian cancer cells. Cancers (Basel). 2021;13(19):4855.","DOI":"10.3390\/cancers13194855"},{"key":"1056_CR70","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.979565","volume":"12","author":"T Cao","year":"2022","unstructured":"Cao T, Dong J, Huang J, Tang Z, Shen H. Identification of fatty acid signature to predict prognosis and guide clinical therapy in patients with ovarian cancer. Front Oncol. 2022;12: 979565.","journal-title":"Front Oncol"},{"key":"1056_CR71","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.777367","volume":"12","author":"L Zhang","year":"2022","unstructured":"Zhang L, Zhao X, Chu H, Zhao H, Lai X, Li J, et al. Serum free fatty acids and g-coupled protein receptors are associated with the prognosis of epithelial ovarian cancer. Front Oncol. 2022;12: 777367.","journal-title":"Front Oncol"},{"issue":"4","key":"1056_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2021.101023","volume":"14","author":"X Zhang","year":"2021","unstructured":"Zhang X, Zhang Z, Liu S, Li J, Wu L, Lv X, et al. CPT2 down-regulation promotes tumor growth and metastasis through inducing ROS\/NF\u03baB pathway in ovarian cancer. Transl Oncol. 2021;14(4): 101023.","journal-title":"Transl Oncol"},{"issue":"13","key":"1056_CR73","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1093\/jnci\/82.13.1107","volume":"82","author":"P Skehan","year":"1990","unstructured":"Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, et al. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst. 1990;82(13):1107\u201312.","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"1056_CR74","first-page":"813","volume":"23","author":"I Kacsir","year":"2022","unstructured":"Kacsir I, Sipos A, B\u00e9nyei A, Janka E, Bugly\u00f3 P,Somsak L, et al. Reactive oxygen species production is responsible for antineoplastic activity of osmium, ruthenium, iridium and rhodium half-sandwich type complexes with bidentate glycosyl hetero-cyclic ligands in various cancer cell models International Journal of Molecular Sciences. 2022;23(2):813.","journal-title":"Reactive oxygen species production is responsible for antineoplastic activity of osmium, ruthenium, iridium and rhodium half-sandwich type complexes with bidentate glycosyl hetero-cyclic ligands in various cancer cell models International Journal of Molec"},{"key":"1056_CR75","doi-asserted-by":"crossref","unstructured":"Kacsir I, Sipos A, Major E, Bajusz N, B\u00e9nyei A, Bugly\u00f3 P, et al. Half-sandwich type platinum-group metal complexes of c-glucosaminyl azines: synthesis and antineoplastic and antimicrobial activities. Molecules. 2023;28(7):3058.","DOI":"10.3390\/molecules28073058"},{"key":"1056_CR76","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/978-1-0716-2891-1_14","volume":"2609","author":"T Kov\u00e1cs","year":"2023","unstructured":"Kov\u00e1cs T, Rauch B, Mik\u00f3 E, Bai P. Methods to assess the role of PARPs in regulating mitochondrial oxidative function. Methods Mol Biol. 2023;2609:227\u201349.","journal-title":"Methods Mol Biol."},{"key":"1056_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101808","volume":"38","author":"C Heged\u0171s","year":"2021","unstructured":"Heged\u0171s C, Juh\u00e1sz T, Fidrus E, Janka EA, Juh\u00e1sz G, Boros G, et al. Cyclobutane pyrimidine dimers from UVB exposure induce a hypermetabolic state in keratinocytes via mitochondrial oxidative stress. Redox Biol. 2021;38: 101808.","journal-title":"Redox Biol"},{"issue":"9","key":"1056_CR78","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1016\/j.bbabio.2018.04.002","volume":"1859","author":"E Miko","year":"2018","unstructured":"Miko E, Vida A, Kovacs T, Ujlaki G, Trencsenyi G, Marton J, et al. Lithocholic acid, a bacterial metabolite reduces breast cancer cell proliferation and aggressiveness. Biochimica et Biophysica Acta - Bioenergetics. 2018;1859(9):958\u201374.","journal-title":"Biochimica et Biophysica Acta - Bioenergetics"},{"key":"1056_CR79","doi-asserted-by":"crossref","unstructured":"Human genomics. The genotype-tissue expression (GTEx) pilot analysis: multitissue gene regulation in humans. Science. 2015;348(6235):648\u201360.","DOI":"10.1126\/science.1262110"},{"issue":"1\u20133","key":"1056_CR80","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.febslet.2004.07.006","volume":"571","author":"JP de Magalh\u00e3es","year":"2004","unstructured":"de Magalh\u00e3es JP, Toussaint O. GenAge: a genomic and proteomic network map of human ageing. FEBS Lett. 2004;571(1\u20133):243\u20137.","journal-title":"FEBS Lett"},{"key":"1056_CR81","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/j.2517-6161.1964.tb00553.x","volume":"26","author":"GEP Box","year":"1964","unstructured":"Box GEP, Cox DR. An analysis of transformations. Journal of the Royal Statistical Society, B. 1964;26:211\u201334.","journal-title":"Journal of the Royal Statistical Society, B"}],"container-title":["GeroScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-023-01056-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11357-023-01056-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-023-01056-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T00:10:23Z","timestamp":1720224623000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11357-023-01056-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,10]]},"references-count":81,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["1056"],"URL":"https:\/\/doi.org\/10.1007\/s11357-023-01056-1","relation":{},"ISSN":["2509-2723"],"issn-type":[{"value":"2509-2723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,10]]},"assertion":[{"value":"13 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The manuscript does not contain data or photographs through which individuals can be identified.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"P\u00e9ter Bai is a CEO and shareholder of Holobiont Diagnostics LTD, a developer of cancer diagnostic tests. Other authors declare no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Primary data is available at the Figshare.com repository\n                      \n                      \n                      ). The results of the RNA sequencing dataset were uploaded to the NCBI SRA database (Submission ID: SUB12949677; BioProject ID: PRJNA944542).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}}]}}